The role of pharmacotherapy in mild to moderate chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) is a major health problem worldwide and most of those afflicted have mild to moderate disease as measured by spirometry. There is mounting evidence that even mild airway obstruction is associated with activity-related dyspnea, exercise limitation, impaire...
Main Authors: | Natya Raghavan, Jordan A. Guenette, Denis E. O’Donnell |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2011-08-01
|
Series: | Therapeutic Advances in Respiratory Disease |
Online Access: | https://doi.org/10.1177/1753465811398373 |
Similar Items
-
New possibilities of pharmacotherapy for chronic obstructive pulmonary disease
by: A. I. Sinopalnikov, et al.
Published: (2018-10-01) -
The lung tissue microbiota of mild and moderate chronic obstructive pulmonary disease
by: Alexa A. Pragman, et al.
Published: (2018-01-01) -
Pulmonary complications after abdominal surgery in patients with mild-to-moderate chronic obstructive pulmonary disease
by: Kim TH, et al.
Published: (2016-11-01) -
Arterial stiffness can occur early in mild-to-moderate chronic obstructive pulmonary disease
by: Waleed Mansour, et al.
Published: (2020-07-01) -
Treatment of mild chronic obstructive pulmonary disease
by: Alex Chee, et al.
Published: (2008-11-01)